BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 10666429)

  • 21. Clostridium difficile infection in patients with ileal pouch-anal anastomosis.
    Shen BO; Jiang ZD; Fazio VW; Remzi FH; Rodriguez L; Bennett AE; Lopez R; Queener E; Dupont HL
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):782-8. PubMed ID: 18467184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
    Tunçcan OG; Ulutan F; Karakuş R
    Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea.
    Massey V; Gregson DB; Chagla AH; Storey M; John MA; Hussain Z
    Am J Clin Pathol; 2003 Jan; 119(1):45-9. PubMed ID: 12520696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer?
    Muñoz P; Giannella M; Alcalá L; Sarmiento E; Fernandez Yañez J; Palomo J; Catalán P; Carbone J; Bouza E
    J Heart Lung Transplant; 2007 Sep; 26(9):907-14. PubMed ID: 17845929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Clostridium difficile colonization at admission to rehabilitation.
    Marciniak C; Chen D; Stein AC; Semik PE
    Arch Phys Med Rehabil; 2006 Aug; 87(8):1086-90. PubMed ID: 16876554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Clostridium difficile a pathogen in the newborn intensive care unit? A prospective evaluation.
    Enad D; Meislich D; Brodsky NL; Hurt H
    J Perinatol; 1997; 17(5):355-9. PubMed ID: 9373839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea.
    Bacon AE; Fekety R
    Diagn Microbiol Infect Dis; 1994 Apr; 18(4):205-9. PubMed ID: 7924215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.
    Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O
    Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test).
    Fille M; Larcher C; Dierich MP; Allerberger F
    Z Gastroenterol; 1998 Feb; 36(2):143-9. PubMed ID: 9544497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital.
    Zumbado-Salas R; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E; Chaves-Olarte E
    Am J Trop Med Hyg; 2008 Aug; 79(2):164-5. PubMed ID: 18689617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitive assays enable detection of serum IgG antibodies against Clostridium difficile toxin A and toxin B in healthy subjects and patients with Clostridium difficile infection.
    Zhao X; Bender F; Shukla R; Kang JJ; Caro-Aguilar I; Laterza OF
    Bioanalysis; 2016 Apr; 8(7):611-23. PubMed ID: 26964649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Fanning S; Kyne L
    Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-associated diarrhea.
    Peled N; Pitlik S; Samra Z; Kazakov A; Bloch Y; Bishara J
    Infect Control Hosp Epidemiol; 2007 Apr; 28(4):377-81. PubMed ID: 17385141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clostridium difficile and diarrhea associated with the use of antibiotics in the origin of nosocomial and community-acquired diarrhea].
    Knobel H; Salvado M; Segura C
    Enferm Infecc Microbiol Clin; 1996 Feb; 14(2):96-100. PubMed ID: 8714156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A specific serum IgA antibody discriminates pneumonia from colonization state in patients with Pseudomonas aeruginosa in sputum culture.
    Yamashita M; Hida Y; Sugimoto H; Takahashi N; Kimura H; Nakatomi Y; Yoshida H; Ishizaki T
    J Microbiol Methods; 2010 Sep; 82(3):198-204. PubMed ID: 20538018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
    Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
    Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
    Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
    J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic antibody response to Clostridium difficile in colonized patients with and without symptoms and matched controls.
    Sánchez-Hurtado K; Corretge M; Mutlu E; McIlhagger R; Starr JM; Poxton IR
    J Med Microbiol; 2008 Jun; 57(Pt 6):717-724. PubMed ID: 18480328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.
    Tian JH; Fuhrmann SR; Kluepfel-Stahl S; Carman RJ; Ellingsworth L; Flyer DC
    Vaccine; 2012 Jun; 30(28):4249-58. PubMed ID: 22537987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis.
    Monaghan TM; Robins A; Knox A; Sewell HF; Mahida YR
    PLoS One; 2013; 8(9):e74452. PubMed ID: 24058568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.